JP2020180110A - cMETモノクローナル結合剤の薬物複合体を含む医薬組成物 - Google Patents
cMETモノクローナル結合剤の薬物複合体を含む医薬組成物 Download PDFInfo
- Publication number
- JP2020180110A JP2020180110A JP2020058049A JP2020058049A JP2020180110A JP 2020180110 A JP2020180110 A JP 2020180110A JP 2020058049 A JP2020058049 A JP 2020058049A JP 2020058049 A JP2020058049 A JP 2020058049A JP 2020180110 A JP2020180110 A JP 2020180110A
- Authority
- JP
- Japan
- Prior art keywords
- binder
- pharmaceutical composition
- amino acid
- cdr
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019066035 | 2019-03-29 | ||
| JP2019066035 | 2019-03-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020180110A true JP2020180110A (ja) | 2020-11-05 |
| JP2020180110A5 JP2020180110A5 (https=) | 2022-08-03 |
Family
ID=73023263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020058049A Pending JP2020180110A (ja) | 2019-03-29 | 2020-03-27 | cMETモノクローナル結合剤の薬物複合体を含む医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2020180110A (https=) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018062402A1 (en) * | 2016-09-29 | 2018-04-05 | Mitsubishi Tanabe Pharma Corporation | Cmet monoclonal binding agents, drug conjugates thereof and uses thereof |
| JP2019504851A (ja) * | 2016-02-10 | 2019-02-21 | メドイミューン・リミテッドMedImmune Limited | ピロロベンゾジアゼピン複合体 |
| JP7177848B2 (ja) * | 2018-03-28 | 2022-11-24 | 田辺三菱製薬株式会社 | cMETモノクローナル結合剤の薬物複合体とその使用 |
-
2020
- 2020-03-27 JP JP2020058049A patent/JP2020180110A/ja active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019504851A (ja) * | 2016-02-10 | 2019-02-21 | メドイミューン・リミテッドMedImmune Limited | ピロロベンゾジアゼピン複合体 |
| WO2018062402A1 (en) * | 2016-09-29 | 2018-04-05 | Mitsubishi Tanabe Pharma Corporation | Cmet monoclonal binding agents, drug conjugates thereof and uses thereof |
| JP7177848B2 (ja) * | 2018-03-28 | 2022-11-24 | 田辺三菱製薬株式会社 | cMETモノクローナル結合剤の薬物複合体とその使用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7490736B2 (ja) | cMETモノクローナル結合剤の薬物複合体とその使用 | |
| KR102443619B1 (ko) | cMET 단일클론 결합제, 이의 약물 접합체 및 이의 용도 | |
| RU2813828C2 (ru) | ЛЕКАРСТВЕННЫЕ КОНЪЮГАТЫ ИЗ МОНОКЛОНАЛЬНЫХ АГЕНТОВ, СВЯЗЫВАЮЩИХ cMET, И ИХ ПРИМЕНЕНИЕ | |
| JP2020180110A (ja) | cMETモノクローナル結合剤の薬物複合体を含む医薬組成物 | |
| TW202028459A (zh) | 靶定syndecan-1及纖維母細胞生長因子受體的雙特異性結合劑 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220726 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220726 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230822 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231004 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240227 |